No Data
No Data
Beijing Yuanlong Yato Culture Dissemination (002878.SZ): The service enterprise clients are mainly concentrated in industries such as beauty, fast-moving consumer goods, internet, mobile, banks, insurance, and pharmaceuticals and healthcare.
On October 11th, Beijing Yuanlong Yato Culture Dissemination (002878.SZ) stated on the investor interaction platform that the company's service enterprise clients are mainly concentrated in industries such as beauty, fast-moving consumer goods, internet plus-related, mobile, banks, insurance, pharmaceuticals, and health. With the national policy vigorously promoting consumer spending, the improvement in end consumer purchasing power will directly drive clients' marketing demands, benefiting the expansion of the company's marketing business sector in terms of business scale and profitability. In addition, the company has established coverage in IP resources, IP content creation and dissemination, IP derivative product design and development, digital cultural and creative product development and operation, as well as B+C channel and IP e-commerce operation.
Ruiang Gene (688217.SH): Zhejiang Health has cumulatively reduced its shareholding by 0.9982%.
RegeneGene (688217.SH) announced on September 27th that it has received a notice from shareholder Zhejiang Da Health regarding the expiration of the period for the shareholding reduction plan of Shanghai RegeneGene Technology Co., Ltd., as of September 27, 2024, Zhejiang Da Health has reduced its holdings of the company's shares by 557,558 shares through centralized bidding trading, accounting for 0.9982% of the total share capital. The time range for this shareholding reduction plan has expired.
Dongfang Ocean (002086.SZ) plans to collaborate with partners to build a product distribution platform and terminal intensification platform to improve the post-sales system of the health industry.
Dongfang Ocean (002086.SZ) announced that its wholly-owned subsidiary Dongfang Ocean Life Technology Co., Ltd. ("Dongfang...
Universal Health International Swings to Profit in Fiscal 2024
Uni Health International (02211.HK) annual revenue of 1.089 billion yuan, a 16.0% year-on-year decrease.
Uni Health (02211.HK) announced on September 25th that as of the end of the fiscal year on June 30, 2024, the group recorded revenue of 1.089 billion yuan, a decrease of 16.0% year-on-year; the attributable income to owners of the company was 0.4 million yuan (2023: a loss of 0.105 billion yuan). Earnings per share were 0.06 yuan (2023: a loss per share of 18.07 yuan). The decrease in attributable losses of the company's owners was mainly due to the group strengthening control over various operating costs through measures to enhance the company's profitability and improve its future.
Express News | Universal Health International Group Holding FY Revenue RMB 1,089 Million
No Data
No Data